Amplyx Pharmaceuticals
USEntry
2017
Hold
4yr
Exit
2021
Who owns Amplyx Pharmaceuticals?
Amplyx Pharmaceuticals was owned by Lundbeckfonden BioCapital through Lundbeckfonden BioCapital (2009 vintage) from 2017 to 2021, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-18
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021
More from Lundbeckfonden BioCapital
Other portfolio companies in the same fund.
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Amplyx Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Amplyx Pharmaceuticals?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Amplyx Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue